Up 18% in a month but still down 62% over the past year, are Cochlear Ltd (ASX: COH) shares a good buy right now?

Revenue Growth: 4% overall revenue growth. Net Profit Growth: 1% net profit growth. Cochlear Implant Revenue: 9% growth in cochlear implant revenue, with 12% growth in systems. Developed Markets Unit ...

MEBOURNE, Australia – Cochlear Ltd., the world's biggest maker of bionic ears, Monday recalled its latest range of hearing implants after a recent unexplained increase in failures. Cochlear shares ...

After wild swings, where does this healthcare share go? The post What on earth's going on with Cochlear shares? appeared ...

After a brutal sell-off, the stock may be gearing up for a recovery. The post 3 reasons to buy Cochlear shares in June ...

Morgans analyst Derek Jellinek downgraded Cochlear Limited (CHEOF – Research Report) to a Hold today and set a price target of A$290.50. The company’s shares closed last Friday at $205.54. According ...

If you want to know who really controls Cochlear Limited (ASX:COH), then you'll have to look at the makeup of its share registry. We can see that institutions own the lion's share in the company with ...

Apple is continuing to bolster its profile in the medtech space, this time through Australian cochlear implant maker Cochlear Limited. The medical device business is launching the first implant sound ...

CochLear Ltd. Unsponsored ADR (CHEOY Quick Quote CHEOY - Free Report) appears an attractive pick, as it has been recently upgraded to a Zacks Rank #2 (Buy). This rating change essentially reflects an ...